In the pharmaceutical industry, AstraZeneca Pharma India Limited is a mid-cap company with a market cap of Rs. 6,822 crore. With global clients, the firm operates in key healthcare sectors such as oncology, respiratory, cardiovascular, renal and metabolic diseases. For the financial year 2021-2022, the board of the company has recommended a final dividend of Rs. 8-per equity share, or 400% on face value 2. AstraZeneca Pharma paid 500.00% dividend, or Rs. 10 per share for the financial year ending March 2022. (ex-dividend 2.00 in Q3). dividend yield at the current share price of 2,708 is 0.36 per cent.
For the purpose of dividend, today the company has announced the record date. AstraZeneca Pharma India said in a BSE filing that “Further to our notice dated May 26, 2022, we would like to inform that the record date for determining the eligibility of shareholders for the payment of final dividend for the financial year 2021-22 is July 8, 2022. The final dividend, if approved by the shareholders, will be paid/remitted to the shareholders on or before September 6, 2022.”
Shares closed down 0.99 per cent on NSE today 2,708, down from its previous close 2735.10. The stock has fallen 25.84 percent in the past year, and so far in 2022, it’s fallen 12.11 percent on a year-to-date (YTD) basis. The stock has lost 10.42 per cent in the last six months and 7.37 per cent in the last month. Shares of AstraZeneca Pharma India are now trading up 26.41 per cent from 52-week high and 10.72 per cent from 52-week low, respectively, on the NSE. Shares hit 52-week high 52-week low of 3,679.95 on June 24, 2021 and 2,445.70 on May 12, 2022. The stock is trading lower than the 5-day, 20-day, 50-day, 100-day and 200-day moving averages based on today’s closing price and as per Value Research, the company is currently in a debt-free status.